Amy Wang is a Ph.D. scientist with a strong background in immunology, who has been working in drug discovery and development for years. With extensive experience in cell-based and biochemical assay development, she is an expert in phenotypic assay development, particularly FACS and Image-based. Amy's broad understanding of drug mechanisms in infectious and autoimmune diseases, immuno-oncology, and neurodegenerative diseases is particularly impressive. Amy is motivated, analytical, and creative, with excellent communication and organizational skills, and is an effective researcher and team contributor. She is currently employed as a Principal Scientist at FogPharma, but has previously held positions at companies such as Farcast Biosciences, Eisai US, and MGI Pharma. Prior to this, Amy was a Research Fellow at Harvard Medical School and a Visiting Fellow at NINDS/NIH.